Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
about
A validated model of serum anti-müllerian hormone from conception to menopauseExtra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competenceGenetic, hormonal and metabolic aspects of PCOS: an updateOvarian hyperstimulation syndrome: pathophysiology, staging, prediction and preventionIndividualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceWhat is the best treatment option for infertile women aged 40 and over?The Bologna criteria for poor ovarian response: a contemporary critical appraisalThe ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive agingThe meaning of anti-Müllerian hormone levels in patients at a high risk of poor ovarian responseFertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessmentIs Anti-Müllerian Hormone Associated With Fecundability? Findings From the EAGeR TrialFemale reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complicationsSerum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewDefining ovarian reserve to better understand ovarian agingAssociation between intrafollicular concentration of benzene and outcome of controlled ovarian stimulation in IVF/ICSI cycles: a pilot studyDoes accelerated reproductive aging underlie premenopausal risk for cardiovascular disease?Impact of breast cancer on anti-mullerian hormone levels in young womenAlcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American womenAnti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundabilityPredictors of pregnancy and live-birth in couples with unexplained infertility after ovarian stimulation-intrauterine insemination.Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.Vaccination with inhibin-α provides effective immunotherapy against testicular stromal cell tumors.Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF?The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropinEffect of anti-Mullerian hormone in culture medium on quality of mouse oocytes matured in vitroLive imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophoreOocyte polarized light microscopy, assay of specific follicular fluid metabolites, and gene expression in cumulus cells as different approaches to predict fertilization efficiency after ICSI.Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.Data-driven assessment of the human ovarian reserve.Follicular fluid placental growth factor is increased in polycystic ovarian syndrome: correlation with ovarian stimulationPrediction of assisted reproductive technique outcome in elevated early follicular phase follicle stimulating hormone with Mullerian inhibiting substance levelSerum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging.N- and O-linked glycosylation of total plasma glycoproteins in galactosemia.Ovarian aging and premature ovarian failure.The physiology and clinical utility of anti-Mullerian hormone in women.The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature.Fertility and age.The use of ovarian reserve markers in IVF clinical practice: a national consensus.
P2860
Q21135308-2AA4472C-361B-4CD7-85E5-F6168E878BDFQ24629523-45EB74BF-1CAC-466F-BEDE-14461128D37CQ26740034-C3B9610D-04FC-40C5-BC77-40CA074E3B90Q26827593-D93B8ECE-C12D-4FC8-906B-EEC953089765Q26829747-1095E126-B7F6-4492-ABAD-4B92DCB4C5E9Q26998406-20D17106-6E25-4E63-86BB-425D70D8DC7FQ27021821-4529F2DB-9357-4539-9E93-D1AA3716C783Q27024729-F8624E8C-AD8B-44F3-8CE4-C7F5F818CF4DQ27026188-E163226E-F32E-451C-B24F-D1E84B87D6BFQ28067035-FF7D2835-BCB0-40BC-8C81-422E337D0213Q28077710-F8C6D501-B5C3-4516-BC6B-7C36EB8EEEB2Q28383121-886A1A96-DDFA-42D6-A4B3-9771CD8A8488Q28383280-9297C11F-11DD-4244-AB99-F0DBD7A4F2CEQ28384104-9B527442-0334-4295-ACF0-6A2D3E2B8813Q28386414-7D2FFA68-A6FE-4AA5-B07C-B9CC42C8A606Q28389255-91A466BD-F3E4-41AE-8859-CD490A731CC8Q28391817-988F6B13-E17E-4528-9D39-2EE73E401558Q28392860-8C31CF2E-F3BF-4E02-84CA-2FBE48B47EBAQ28394989-1CE8DC44-093B-4B5A-AF7C-C0FFAE587FEBQ28396276-115EDE40-08FA-4B70-B093-D7502ABE7B49Q30352472-024B5C4C-3298-4EFD-8899-466BD18E782FQ30766464-6FEC243A-DB4F-4561-B715-33D584EDAED7Q33572938-29D9590A-821A-4858-8A26-EE8CAB0E89E7Q33604947-10A8898F-BD24-4D00-AAF5-CE94910168D4Q33761614-966A8D38-3DB5-4500-9545-11D12F1E5EA3Q33763232-54466C9D-6897-4963-8486-E314E1B60F8FQ33781591-87524300-75DC-419C-BA19-5DFBE488F557Q33827655-D8124FD1-95E5-4A7A-B6BA-A066EDD9497FQ33952002-5FD45550-2BA9-4C27-A022-54B4DF367D70Q34024795-1F4810EC-820F-4967-8884-15803A084FADQ34116423-5FE68631-011F-4BFE-8E42-F9248771ECE5Q34196639-7BAEDAD3-0870-4FCF-BE70-6234679947B5Q34226385-7C119120-6607-4489-AA52-AE9820105AE1Q34255040-6EDDBCF7-C034-4176-B744-D903429FDB3EQ34320339-AC343802-A899-4656-B6F3-DB3142CFE64FQ34330442-7179D60F-0F9A-46EC-9078-E9083527457CQ34398233-6DD02FAB-5ADB-4700-AE6C-3D4F61EA2D72Q34404612-C9FD693C-FBEE-4C6F-8BF1-9DACAC8E6D48Q34472773-9E93CD13-985F-4FDB-B4B7-77EB8CF8E000Q34500365-2DDECD57-86E3-4E3C-A429-17307328E915
P2860
Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-Mullerian hormone (AMH) a ...... reproductive technology (ART).
@en
Anti-Mullerian hormone
@nl
type
label
Anti-Mullerian hormone (AMH) a ...... reproductive technology (ART).
@en
Anti-Mullerian hormone
@nl
prefLabel
Anti-Mullerian hormone (AMH) a ...... reproductive technology (ART).
@en
Anti-Mullerian hormone
@nl
P2093
P2860
P356
P1476
Anti-Mullerian hormone (AMH) a ...... reproductive technology (ART).
@en
P2093
A Carducci Artenisio
G Sighinolfi
P2860
P304
P356
10.1093/HUMUPD/DMP036
P577
2009-09-30T00:00:00Z